Shi, T.; Iwama, H.; Fujita, K.; Kobara, H.; Nishiyama, N.; Fujihara, S.; Goda, Y.; Yoneyama, H.; Morishita, A.; Tani, J.;
et al. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2021, 22, 13071.
https://doi.org/10.3390/ijms222313071
AMA Style
Shi T, Iwama H, Fujita K, Kobara H, Nishiyama N, Fujihara S, Goda Y, Yoneyama H, Morishita A, Tani J,
et al. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 2021; 22(23):13071.
https://doi.org/10.3390/ijms222313071
Chicago/Turabian Style
Shi, Tingting, Hisakazu Iwama, Koji Fujita, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Yasuhiro Goda, Hirohito Yoneyama, Asahiro Morishita, Joji Tani,
and et al. 2021. "Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells" International Journal of Molecular Sciences 22, no. 23: 13071.
https://doi.org/10.3390/ijms222313071
APA Style
Shi, T., Iwama, H., Fujita, K., Kobara, H., Nishiyama, N., Fujihara, S., Goda, Y., Yoneyama, H., Morishita, A., Tani, J., Yamada, M., Nakahara, M., Takuma, K., & Masaki, T.
(2021). Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences, 22(23), 13071.
https://doi.org/10.3390/ijms222313071